Altered lipidomic profiles in patients with and without osteonecrosis of the femoral head after 1‐month glucocorticoid treatment
Open Access
- 14 February 2021
- journal article
- letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (2), e298
- https://doi.org/10.1002/ctm2.298
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81672157, 81871742)
This publication has 10 references indexed in Scilit:
- Trans-omic profiling between clinical phenoms and lipidomes among patients with different subtypes of lung cancerClinical and Translational Medicine, 2020
- The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosisJournal of Autoimmunity, 2020
- Serum Biomarkers Related to Glucocorticoid‐Induced Osteonecrosis of the Femoral Head: A Prospective Nested Case‐Control StudyJournal of Orthopaedic Research, 2019
- Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositisArthritis Research & Therapy, 2018
- Chronic dexamethasone exposure markedly decreased the hepatic triglyceride accumulation in growing goatsGeneral and Comparative Endocrinology, 2018
- Metabolomic study of the bone trabecula of osteonecrosis femoral head patients based on UPLC–MS/MSMetabolomics, 2016
- Unique plasma metabolomic signature of osteonecrosis of the femoral headJournal of Orthopaedic Research, 2015
- High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosusClinical Rheumatology, 2015
- Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathwayRheumatology, 2008
- Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRILupus, 2005